Plain-English translation of NCT06545591 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at special proteins in your blood called sTREM that may help doctors predict how well you will recover after stroke treatment. The study involves taking blood samples before, immediately after, and 24 hours after your clot-removal procedure (called endovascular thrombectomy) to measure these proteins and see if they can tell us who is more likely to have a good recovery.
Even when doctors successfully remove a blood clot from the brain during stroke treatment, some patients still have poor outcomes. This medication is trying to understand why this happens by studying immune system markers in the blood that might predict which patients will struggle to recover, so doctors can better identify and help high-risk patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood drawn at three times: right before your clot-removal procedure, right after the procedure is done, and again 24 hours later. The researchers will track your recovery over the next three months and compare your blood marker levels to your outcome. No extra medications or procedures are needed beyond your standard stroke care.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China
Enrollment target
~300 participants
Started
July 2024
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xingzhi Wang, MD
The Affiliated Hospital of Xuzhou Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.